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Abstract
Purpose
To investigate the concurrent, face and content validity of an evaluation tool for Myofascial
Adhesions in Patients after Breast Cancer (MAP-BC evaluation tool).
Methods
1) Concurrent validity of the MAP-BC evaluation tool was investigated by exploring correla-
tions (Spearman’s rank Correlation Coefficient) between the subjective scores (0 –no adhe-
sions to 3 –very strong adhesions) of the skin level using the MAP-BC evaluation tool and
objective elasticity parameters (maximal skin extension and gross elasticity) generated by the
Cutometer Dual MPA 580. Nine different examination points on and around the mastectomy
scar were evaluated. 2) Face and content validity were explored by questioning therapists
experienced with myofascial therapy in breast cancer patients about the comprehensibility
and comprehensiveness of the MAP-BC evaluation tool.
Results
1) Only three meaningful correlations were found on the mastectomy scar. For the most lateral
examination point on the mastectomy scar a moderate negative correlation (-0.44, p = 0.01)
with the maximal skin extension and a moderate positive correlation with the resistance ver-
sus ability of returning or ‘gross elasticity’ (0.42, p = 0.02) were found. For the middle point on
the mastectomy scar an almost moderate positive correlation with gross elasticity was found
as well (0.38, p = 0.04) 2) Content and face validity have been found to be good. Eighty-nine
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percent of the respondent found the instructions understandable and 98% found the scoring
system obvious. Thirty-seven percent of the therapists suggested to add the possibility to
evaluate additional anatomical locations in case of reconstructive and/or bilateral surgery.
Conclusions
The MAP-BC evaluation tool for myofascial adhesions in breast cancer patients has good
face and content validity. Evidence for good concurrent validity of the skin level was found
only on the mastectomy scar itself.
Introduction
Awareness of the contribution of myofascial dysfunctions to pain after breast cancer treatment
has increased. [1, 2] Torres Lacomba et al reported a prevalence rate of the myofascial pain
syndrome of 45% one year after breast cancer surgery. [3] Both myofascial trigger points and
adhesions and/or restrictions between the myofascial tissues layers can contribute to a patient’s
pain complaint.[3–7]
For myofascial trigger points, several criteria to determine their presence have already been
postulated.[3, 8, 9] For the evaluation of myofascial adhesions, the Myofascial Adhesions in
Patients after Breast Cancer (MAP-BC) evaluation tool has been developed by De Groef et al.
[10] This tool evaluates the degree of myofascial adhesions at 7 anatomical locations (axillary
and breast region scars, pectoral muscles region, axilla, frontal chest wall, lateral chest wall and
inframammary fold) in breast cancer patients. At each location, the degree of myofascial adhe-
sions is scored at three levels of depth (skin, superficial and deep level) on a 4-points scale
(between no adhesions and very strong adhesions). Additionally, a total score between 0 and 9
is calculated, i.e. the sum of the different levels of each location.
The Cosmin Checklist distinguishes three domains in assessing the quality of a measure-
ment instrument, i.e. reliability, validity and responsiveness.[11] The reliability of the MAP-
BC evaluation tool has already been investigated.[10] Interrater agreement of the different lev-
els separately was moderate to good (Weighted Kappa (WK) 0.62 to 0.90) for the scars. For
almost all levels of the non-scar locations moderate agreement was reached (Weighed Kappa
> 0.50), except for 2 levels (superficial level of the lateral chest wall and skin level of the infra-
mammary fold) were only poor agreement was found (WK 0.41 to 0.44). Interrater reliability
of the total scores was very good for the scars as well (Intraclass Correlation Coefficient (ICC)
0.82 to 0.99). At non-scar locations, good interrater reliability was reached (ICC 0.76–0.87),
except for the inframammary fold (ICC 0.71).
The validity of the MAP-BC evaluation tool has not yet been investigated. Firstly, concur-
rent validity should be explored by comparing the subjective scores of the MAP-BC evaluation
tool to another objective measurement tool. However, to our knowledge, no objective mea-
surement tool or gold standard for the evaluation of the degree of myofascial adhesions in
breast cancer patients exists. Nevertheless, several objective measurement tools exist to mea-
sure elasticity or stiffness of scars in other populations.[12] The most widely used evaluation
tool is the Cutometer Dual MPA 580 Skin Elasticity Meter.[12] The intra- and interrater reli-
ability of the Cutometer has been found to be good to excellent in normal skin and less severe
hypertrophic burn scars.[13–15] Reliability in hypertrophic scars is only moderate.[13, 14] In
the study of Draaijers et al objective measurements with the Cutometer had moderate and sta-
tistically significant correlations with subjective palpation of the pliability of burn scars.[15]
MAP-BC evaluation tool: Validity
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The first aim of this study was to explore the concurrent validity of the MAP-BC evaluation
tool by comparing its subjective scores with objective elasticity parameters generated by the
Cutometer. Second, face and content validity were explored by questioning physical therapists
experienced with myofascial therapy in breast cancer patients. For concurrent validity, we
hypothesize 1) a negative correlation for the maximal skin extension and 2) a positive correla-
tion for gross elasticity, both measured with the Cutometer, on the one hand with the degree
of myofascial adhesions at the skin level measured with the MAP-BC evaluation tool on the
other hand. Second, face and content validity should be explored by questioning other persons
with expertise in this domain. With the validation of the MAP-BC evaluation tool better
insight in how to evaluate soft tissue restrictions in daily clinical practice will be provided.
Methods
This study was approved by the Ethical Committee of the University Hospitals of Leuven
(s54579). All participants (breast cancer patients and medical workers) gave written informed
consent to participate.
Part 1: Concurrent validity
Participants. A convenience sample of 30 women treated for breast cancer were recruited
at the Multidisciplinary Breast Center of the University Hospitals of Leuven. Inclusion criteria
were 1) unilateral modified radical mastectomy as treatment for breast cancer; 2) the mastec-
tomy scar had to be healed. Patients with complications such as lymphedema and seroma were
excluded.
MAP-BC evaluation tool. The MAP-BC evaluation tool was used for the subjective
assessment of myofascial adhesions by palpation. The degree of adhesions was scored at three
depth levels (skin, superficial and deep) and each time on a 4-points scale (between 0—no
adhesion and 3—very strong adhesions). Additionally, a total score with a maximum score of
9 was calculated, i.e. the sum of the different levels of each location. More details and instruc-
tions on how to use the MAP-BC evaluation tool are reported elsewhere.[10]
Cutometer. The Cutometer Dual MPA 580 (Courage and Khazaka Electronic GmbH,
Cologne, Germany) measures the elasticity of the skin using negative pressure which deforms
the skin mechanically. The Cutometer measures the vertical deformation of the skin in milli-
meters when the skin is pulled into the circular aperture (6 mm in diameter and 2 mm in
height) of the probe with an exactly defined vacuum pressure. In this study, a vacuum load of
400 mbar was used and suction and relaxation time of 2 seconds. Fig 1 illustrates the deforma-
tion-time curve of the Cutometer. Following parameters were used for analysis: first, the maxi-
mal skin extension (Uf) is the highest point of the curve (at the end of the vacuum period). It
represents the passive behavior of the skin to a force. This parameter gives an implication of
the firmness of the skin and has been shown to be the most reliable parameter on scars.[14, 15]
We hypothesized a negative correlation between maximal skin extension and the degree of
myofascial adhesions at the skin level measured with the MAP-BC evaluation tool. Second, the
gross elasticity (Ua/Uf) is expressed as the ratio between the final retraction (Ua) and the maxi-
mal skin extension (Uf), which expresses resistance versus ability of returning. We hypothe-
sized a positive correlation between gross elasticity and the degree of myofascial adhesions at
the skin level since resistance versus ability of returning of strong adhesions will approximate
toward 1 (100%).[16, 17] In the output of the Cutometer these parameters can be found under
R0 and R2, respectively.
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Procedure. The subjects were asked to lie down in the predetermined position, shown in
Fig 2. In case of pain or discomfort, the subject was allowed to place the arms alongside the
body.
The evaluation of the elasticity of the scar tissue was limited to nine measuring points on
and around the scar (Fig 2) because assessment of the complete upper body is neither feasible
nor practical. The measuring points are located at the center and opposite ends of the scar and
2 cm above and below the scar. Measuring points 1, 2 and 3 are situated at the lateral extremity
of the scar, near the armpit; measuring points 4, 5 and 6 at the center of the scar and measuring
points 7, 8 and 9 at the medial extremity of the scar, near the sternum. The nine measuring
points are marked on the skin using a circular template of the probe of the Cutometer device.
First, measuring point 2, the lateral end point of the scar, was drawn. The circle was drawn in
such a manner that the end point of the scar forms the center of this circle. Subsequently, one
circle is drawn two centimeters above and two centimeters below the examination point 2 for
point 1 and 3, respectively. This approach was repeated at the opposite extremity of the scar
for measuring point 7, 8 and 9. In order to draw the cluster of circles at the center of the scar,
the exact center point of the scar was determined by using a measuring tape. Foregoing proce-
dure was repeated for measuring point 4, 5 and 6.
Fig 1. Time-deformation curve of the Cutometer.
https://doi.org/10.1371/journal.pone.0193915.g001
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After identifying the measurement points, the rater palpated these nine points and the per-
ceived adhesions at the skin level were scored from 0 to 3 conforming to the MAP-BC evalua-
tion tool. The same rater assessed the degree of adhesion with the Cutometer, in the same
order and on equivalent measuring points. The computer screen with the results of the Cut-
ometer was turned away from the rater to maximize blinding for the results of the reference
test. Testing was performed by one rater with more than 3 years of experience in treatment of
myofascial dysfunctions in breast cancer patients. For the testing with the Cutometer a 2-hour
training was implemented.
Statistical analysis. The data were analyzed by the statistical software package SPSS 23.0.
The concurrent validity was established by means of a Spearman’s rank Correlation Coefficient
since data were not normally distributed. Correlations between the scores of the subjective
evaluation of the skin level with the MAP-BC evaluation tool and the parameters maximal skin
extension (Uf) and gross elasticity (Ua/Uf) measured with the Cutometer were explored. Arbi-
trary guidelines for interpretation of the correlations are formulated by Evans.[18] A correla-
tion coefficient between 0 and 0.19 indicate a very weak correlation, between 0.20–0.39 weak,
between 0.40–0.59 moderate, between 0.60–0.79 strong and between 0.80–1.00 very strong. A
convenience sample was recruited without power analysis.
Part 2: Content and face validity
Face validity is the degree to which the items of the MAP-BC evaluation tool indeed look as
though they are an adequate reflection of the construct to be measured.[11] This can be exam-
ined by asking the respondent whether the instructions and scoring system of the evaluation
Fig 2. Overview of the nine examination points.
https://doi.org/10.1371/journal.pone.0193915.g002
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tool are understandable and obvious. Content validity is the degree to which the content of the
MAP-BC evaluation tool is an adequate reflection of the construct to be measured. This can be
examined by analyzing the answers given to the questions about the comprehensiveness of the
evaluation tool.
Medical workers, familiar with the application of myofascial therapy in breast cancer
patients, were recruited through two educational institutes in Flanders (Belgium) and the
Netherlands. The medical workers were asked to complete a questionnaire on face and content
validity. The medical workers were recruited through two educational institutes in Flanders
(Belgium) and the Netherlands. The questionnaire consisted of 3 questions: 1) ‘Were the
instructions of the MAP-BC evaluation tool clear and easy to understand?’, 2) ‘Did you find
the scoring system obvious?’ And 3) ‘Did you find the MAP-BC evaluation tool complete?’.
Physical therapists who gave a negative answer to any of the questions were asked to provide a
more detailed explanation.
In the context of determining the content validity, the relevance of the 7 anatomical loca-
tions of the original MAP-BC evaluation tool was explored. The MAP-BC evaluation tool was
administered in the 30 participants of Part 1 of this study. First, for each anatomical location
the minimum, maximum, median and interquartile range of the degree of myofascial adhe-
sions is given. Second, prevalence rate of myofascial adhesions at each location is given.
Results
Thirty women after axillary lymph node dissection and modified radical mastectomy for breast
cancer were available for testing of concurrent validity. Patients characteristics are given in
Table 1. Mean (standard deviation) room temperature and humidity were 23.3˚ (0.7) and
30.7% (4.4), respectively. Median (interquartile range) total score of the degree of myofascial
adhesions at the mastectomy scar measured with the MAP-BC evaluation tool was 4 (3–6).
Mean maximal skin extension (Uf) and gross elasticity (Ua/Uf) were 0.79 (0.16) mm and 0.72
(0.06), respectively. The correlation between maximal skin extension (Uf) and gross elasticity
(Ua/Uf) was moderate and statistically significant (-0.409, p = 0.025).
Part 1: Concurrent validity
An overview of the concurrent validity is given in Table 2. Except for 3 points, no correlations
between the subjective evaluation of myofascial adhesion at skin level with the MAP-BC evalu-
ation tool and the objective parameters of the Cutometer were found. All significant correla-
tions were found at measurement points on the mastectomy scar. For the most lateral
examination point on the mastectomy scar a moderate negative correlation (-0.442, p = 0.014)
Table 1. Patients’ characteristics (N = 30). Mean (SD) and Number (%) are given.
Age (years) 53.9 (10.9)
BMI (kg/m2) 25.2 (4.0)
Time after surgery (years) 1.2 (0.5)
Chemotherapy 13 (43%)
Neo-adjuvant chemotherapy 11 (37%)
Radiotherapy 30 (100%)
Endocrine therapy 24 (80%)
Target therapy 5 (14%)
N = Number; SD = Standard Deviation; BMI = Body Mass Index
https://doi.org/10.1371/journal.pone.0193915.t001
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with the maximal skin extension was found, meaning the greater the subjective score, the less
extension of the scar. At the same point and in the middle of the scar, a moderate positive cor-
relation between the subjective evaluation of the skin level and gross elasticity was found
(0.416, p = 0.022 and 0.380, p = 0.038, respectively). These correlations indicated that the
higher the subjective score, the greater the ratio between the maximal skin extension and the
ability to return or ‘gross elasticity’.
Part 2: Face and content validity
Forty-three medical workers completed the questionnaire on face and content validity. Twenty
(47%) of them were physical therapists, 9 (21%) were edema therapists and 14 (32%) were skin
therapists. Mean age was 39.1 (10.8) years and mean years of experience in myofascial therapy
in breast cancer patients was 4.8 (6.7) years.
Thirty-nine (89%) medical workers found the instructions of the MAP-BC evaluation tool
understandable. Two persons suggested to describe the amount of pressure for palpation in
the instructions. One person found the wording ‘early restriction’ not clear. Forty-two (98%)
medical workers found the scoring system obvious. One person made the remark that distinc-
tion between the different depth levels may be difficult in case of very stiff adhesions.
Twenty-seven (63%) medical workers found the MAP-BC evaluation tool complete. Several
persons (exact number between parentheses) suggested to add six more anatomical locations:
scars after reconstruction (n = 2), the back (n = 5), the arm for the brachial fascia (n = 2), the nip-
ple (n = 1), the abdomen (n = 2) and the platysma or neck region (n = 5). Additionally, two per-
sons indicated they want to be able to report the direction of the myofascial restriction and one
person made the remark that the MAP-BC evaluation tool is not suitable for bilateral surgery.
For each anatomical location the minimum, maximum, median and interquartile range of
the degree of myofascial adhesions and the prevalence rate of myofascial adhesions are given in
Table 3. All patients had to a certain extent myofascial adhesions at the mastectomy scar. Adhesions
at the inframammary fold were the least frequent. At all locations, except the lateral chest wall and
the inframammary fold, the full range of the scoring system (degree of adhesions 0–3) was used.
Discussion
In the first part of this study the concurrent validity of the MAP-BC evaluation tool was inves-
tigated. Nine different examination points on and around the mastectomy scar were evaluated
Table 2. Concurrent validity.
Maximal skin extension (Uf) Gross elasticity (Ua/Uf)
Point 1 –skin -0.276 (p = 0.140) 0.115 (p = 0.545)
Point 2 –skin -0.442 (p = 0.014) 0.416 (p = 0.022)
Point 3 –skin -0.326 (p = 0.079) -0.120 (p = 0.528)
Point 4 –skin -0.333 (p = 0.073) -0.063 (p = 0.743)
Point 5 –skin -0.111 (p = 0.558) 0.380 (p = 0.038)
Point 6 –skin -0.106 (p = 0.577) 0.037 (p = 0.844)
Point 7 –skin 0.097 (p = 0.608) 0.292 (p = 0.117)
Point 8 –skin 0.016 (p = 0.932) 0.253 (p = 0.117)
Point 9 –skin -0.091 (p = 0.631) -0.061 (p = 0.749)
Uf = maximal skin extension, defined as the highest point of the curve (at the end of the vacuum period); Ua/
Uf = Gross elasticity, expressed as the ratio between the final retraction (Ua) and the maximal skin extension (Uf),
which expresses resistance versus ability of returning.
https://doi.org/10.1371/journal.pone.0193915.t002
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at the skin level. Only three meaningful and significant correlations were found at the lateral
end and the middle of the mastectomy scar. The subjective evaluation of the skin level with the
MAP-BC evaluation tool was significantly correlated to the maximal skin extension and the
resistance versus ability of returning or ‘gross elasticity’ measured with the Cutometer. Addi-
tionally, good face and content validity of the MAP-BC were found.
At the most lateral examination point on the mastectomy scar itself, a negative correlation
between the subjective evaluation of the skin level of the mastectomy scar and the maximal
skin extension measured with the Cutometer was found. This negative correlation indicates
that a higher subjective score for myofascial adhesions is correlated to a smaller skin extension
Table 3. For each anatomical location (7) the minimum, maximum, median and interquartile range of the degree of myofascial adhesions is given. Additionally,
prevalence rate of myofascial adhesions at that location is given.
Minimum Median (IQR) Maximum Number (%) of patients with adhesions
Mm pectoralis region
Skin 0 0 (0–1) 2 13 (43%)
Superficial 0 2 (1–2) 3 27 (90%)
Deep 0 2 (1–2) 3 28 (93%)
Total score 0 4 (2–5) 7 29 (97%)
Axilla
Skin 0 1 (0–1) 2 17 (57%)
Superficial 0 1 (1–2) 3 27 (90%)
Deep 0 1 (1–2) 3 25 (83%)
Total score 0 3 (2–5) 8 29 (97%)
Frontal Chest Wall
Skin 0 1 (0.75–2) 2 23 (76%)
Superficial 0 1 (0–2) 3 22 (73%)
Total score 0 2 (1–4) 5 24 (80%)
Lateral Chest Wall
Skin 0 1 (1–1) 2 28 (93%)
Superficial 0 1 (0–2) 2 21 (70%)
Deep 0 1 (0–2) 2 19 (63%)
Total score 0 3 (1–5) 6 29 (97%)
Inframammary fold
Skin 0 1 (0–1) 2 16 (53%)
Superficial 0 0 (0–1.25) 2 14 (47%)
Deep 0 0 (0–1) 2 13 (43%)
Total score 0 1 (0–3.25) 6 21 (70%)
Axillary scar
Skin 0 1 (1–1.25) 2 28 (93%)
Superficial 0 0 (0–1) 2 12 (40%)
Deep 0 0 (0–1) 3 10 (33%)
Total score 0 1 (1–4) 6 29 (97%)
Mastectomy Scar
Skin 1 2 (1–2) 3 18 (60%)
Superficial 0 1 (1–2) 3 26 (87%)
Deep 0 1 (1–2) 3 25 (83%)
Total score 1 4 (3–6) 8 30 (100%)
IQR = Interquartile Range
https://doi.org/10.1371/journal.pone.0193915.t003
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generated by the Cutometer. This result is similar to the correlation between the subjective
evaluation of pliability of burn scars and maximal skin extension in the study of Draaijers et al.
[15] At the same point and in the middle of the scar, a positive correlation between the subjec-
tive evaluation of the skin level and gross elasticity was found. This correlation indicates that
the higher the subjective score, the greater the resistance versus the ability of returning or
‘gross elasticity’. ‘Gross elasticity’ takes into account two parameters. In strong adhesions,
maximal skin extension will be rather small but final retraction or the ability to return will be
rather great, approximating a ratio of 1 or 100%. Similar correlations between gross elasticity
and deep burn scars[16] or younger skin[17] have been found. Based on only these three sig-
nificant correlations, we could conclude moderate concurrent validity of the MAP-BC evalua-
tion tool for the mastectomy scar at skin level only.
The Cutometer was chosen as objective measurement tool because of the good reliability
and validity[13, 14] and the widely-accepted use as objective tool in the evaluation of skin elas-
ticity in other populations. However, some characteristics of the Cutometer may explain the
poor correlations with the MAP-BC evaluation tool. First, only the skin is evaluated with the
Cutometer. More specific, only the epidermis and (papillary) dermis are evaluated. Breast and
axillary surgery and radiotherapy in breast cancer patients cause scar tissue formation, fibrosis
and adhesions at all levels of soft tissues of the upper body. Therefore, the MAP-BC was
designed to evaluate the skin level and deeper myofascial structures. Second, the Cutometer
produces a vertical deformation of the skin while the palpation is more in the horizontal plane.
Third, the Cutometer has not been used before in breast cancer patients. Scar tissue formation
in burns or skin grafts may be too different from the fibrosis, adhesions and scar tissue forma-
tion in breast cancer patients. In burns or skin grafts, typical characteristics are an aberrant
color, rough surface texture and/or increased thickness (i.e. hypertrophy).[19] In breast cancer
patients, radiotherapy-induced fibrosis, linear scars from breast and axillary surgery and inter-
nal scar tissue formation in the surgical area may be present. For example, during the mastec-
tomy procedure the glandular tissue is removed and the skin is folded towards the thorax.
Additionally, drains are inserted after surgery. These internal wounds heal by forming scar tis-
sue and adhesions which are of a different type compared to burn scars. Therefore, it is possi-
ble that certainly for measurement points around the mastectomy scar, the Cutometer
measures a different construct than the MAP-BC evaluation tool whereby no meaningful cor-
relations were found. Fourth, skin elasticity measurements with the Cutometer are localized at
a very small surface of 6 mm diameter and measurements are sensitive to location changes.
[13] The MAP-BC evaluation tool measures a larger surface area. Possibly, the (small) differ-
ences in skin elasticity in the larger surface are not detectable by palpation and the score of the
MAP-BC evaluation tool represents a mean score of the larger surface.
Other objective evaluation tools to measure scar elasticity do exist but have their limitations
as well.[12] First, comparable to the Cutometer is the DermaLab Suction Cup. Reliability has
been found to be good in normal skin, burn scars and fibrotic skin.[20, 21] However, this
device measures the force necessary to lift the skin a certain height and therefore may be lim-
ited in use in very stiff scars or adhesions. Second, pressure methods or ‘tonometers’ are not
useful in the breast cancer population because they are not applicable above bone structures
(e.g. ribs).[12, 19, 21] Third, torsion methods may be suitable since they use a horizontal defor-
mation force more likely to the palpation method in the MAP-BC evaluation tool. However,
usefulness of the torsion method in scar assessment has not yet been investigated. Only one
study has used this method in the evaluation of skin grafts.[22] Fourth, extension methods or
‘extensometers’ stretch the skin between two tabs to assess differences in extensibility or stiff-
ness. This may be useful to compare with the MAP-BC, however this is again a vertical defor-
mation and to our knowledge scientific results are limited.[12]
MAP-BC evaluation tool: Validity
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In the second part of this study, face and content validity were investigated. The instruc-
tions were understandable and the scoring system was obvious for almost all medical workers.
The comprehensibility of the questionnaire was very good. The remark on the description of
the amount of pressure for palpation of the different depth levels was given by 2 persons with
only 2 and 3 months experience in myofascial therapy, respectively. For therapists with only
little experience in the evaluation and treatment of myofascial adhesions a more elaborated
description on the palpation techniques may indeed be useful. For the skin level the amount of
pressure can be compared to the pressure on an eyelid. For the other depth levels, an adequate
description of the amount of pressure is more complicated. Another person indicated that the
wording ‘early restriction’ was not clear.
Most remarks were made on the completeness of the MAP-BC evaluation tool. The authors
included the most frequent affected anatomical locations after unilateral mastectomy or breast
conserving surgery, based on expert opinions and literature. In case of bilateral surgery and/or
reconstructive surgery it may indeed be useful to examine the back (in case of e.g. latissimus
dorsi flap reconstruction), the abdomen (in case of e.g. Deep Inferior Epigastric Perforators
flap) and additional scars. Therefore, the authors suggest adding an ‘empty’ illustration on the
MAP-BC evaluation tool that can be used for additional anatomical regions, if necessary. This
additional illustration can also be used, for example, at the nipple, the arm, the platysma and
the neck as suggested. Currently, the direction of the myofascial restriction is not incorporated
in the scoring system. However, it may be clinically relevant to draw the direction of the
restriction on the illustration. At last, content validity is illustrated by the variability of the
MAP-BC in this representative sample of breast cancer patients. From the prevalence rate of
myofascial adhesions, it appears that all anatomical locations are relevant. The scars are the
most relevant and the inframammary fold the least. At all locations, a minimum total score
was noticed and at five out of seven locations the maximum total score was reached. These
results add to the good content validity and the relevance of all items of the MAP-BC evalua-
tion tool.
Strengths and limitations
The measurements were performed in a highly-standardized manner. The environmental fac-
tors had small standard deviations indicate they were quite constant over all measurements.
Face and content validity were investigated in a substantially large (N = 43) group of therapists
experienced in myofascial therapy. Due to practical reasons and limitations of the Cutometer
it was not possible to examine other anatomical locations of the MAP-BC evaluation tool. And
finally, no power calculation was performed to determine sample size.
Future research
Future research should explore the usefulness of the above-mentioned objective instruments
for the evaluation of myofascial adhesions in breast cancer patients. Additionally, the utility of
ultrasound elastography for the evaluation of soft tissue elasticity and stiffness should be
explored. More and more research has been done on the use of different kinds of ultrasound
elastography for the evaluation of mechanical properties of tissue, including muscle stiffness,
with promising results.[23] Possibly, the construct measured with ultrasound elastography
leans more towards the construct measured with the MAP-BC evaluation tool. Future research
should explore the correlation between these two evaluation tools. In addition to reliability
and validity, responsiveness of the MAP-BC evaluation tool should be explored.[11]
The MAP-BC evaluation tool shows very good face and content validity, indicating the tool
is useful in clinical practice. The authors suggest adding an additional blank illustration for the
MAP-BC evaluation tool: Validity
PLOS ONE | https://doi.org/10.1371/journal.pone.0193915 March 9, 2018 10 / 12
evaluation of additional myofascial adhesions at other anatomical locations. Identifying the
exact location and degree of adhesions is essential for steering treatment. The MAP-BC evalua-
tion tool is developed specific for scars related to (breast) cancer treatments. Traditional scar
tissue evaluation tools such as the Patient and Observer Scar Assessment Scale (POSAS) are
hard to apply in the cancer population because the different types of scar tissue. The MAP-BC
may be crucial to fill this gap in daily clinical practice.
Conclusion
Based on only three significant correlations, we could conclude moderate concurrent validity
of the MAP-BC evaluation tool for the mastectomy scar itself. Possibly, other objective mea-
surement tools are better suited to explore the concurrent validity of the MAP-BC evaluation
tool. Face and content validity have been found to be good.
Acknowledgments
We would like to thank the medical coworkers of the Berekuyl Academy (The Netherlands)
and Oedema (Flanders, Belgium) for their valuable contribution in the validity testing of the
MAP-BC evaluation tool.
Author Contributions
Conceptualization: An De Groef, Marijke Van Kampen, Mieke Anthonissen, Eric Van den
Kerckhove, Marie-Rose Christiaens, Inge Geraerts, Nele Devoogdt.
Data curation: An De Groef, Peter Moortgat, Nele Devoogdt.
Formal analysis: An De Groef, Peter Moortgat, Inge Geraerts, Nele Devoogdt.
Funding acquisition: Marijke Van Kampen, Marie-Rose Christiaens, Patrick Neven, Nele
Devoogdt.
Investigation: An De Groef.
Methodology: An De Groef, Marijke Van Kampen, Peter Moortgat, Mieke Anthonissen, Eric
Van den Kerckhove, Inge Geraerts, Nele Devoogdt.
Project administration: An De Groef.
Supervision: Marijke Van Kampen, Eric Van den Kerckhove, Marie-Rose Christiaens, Patrick
Neven, Nele Devoogdt.
Writing – original draft: An De Groef, Nele Devoogdt.
Writing – review & editing: Marijke Van Kampen, Peter Moortgat, Mieke Anthonissen, Eric
Van den Kerckhove, Marie-Rose Christiaens, Patrick Neven, Inge Geraerts.
References
1. Stubblefield MD, Keole N. Upper Body Pain and Functional Disorders in Patients With Breast Cancer.
PM & R. 2013; 6(2):170–83.
2. Cheville AL, Tchou J. Barriers to rehabilitation following surgery for primary breast cancer. J Surg
Oncol. 2007; 95(5):409–18. https://doi.org/10.1002/jso.20782 PMID: 17457830
3. Torres Lacomba M, Mayoral del Moral O, Coperias Zazo JL, Gerwin RD, Goni AZ. Incidence of myofas-
cial pain syndrome in breast cancer surgery: a prospective study. The Clinical journal of pain. 2010; 26
(4):320–5. https://doi.org/10.1097/AJP.0b013e3181c4904a PMID: 20393267
MAP-BC evaluation tool: Validity
PLOS ONE | https://doi.org/10.1371/journal.pone.0193915 March 9, 2018 11 / 12
4. Lewit K, Olsanska S. Clinical importance of active scars: abnormal scars as a cause of myofascial pain.
J Manipulative Physiol Ther. 2004; 27(6):399–402. https://doi.org/10.1016/j.jmpt.2004.05.004 PMID:
15319762
5. Fourie WJ. Considering wider myofascial involvement as a possible contributor to upper extremity dys-
function following treatment for primary breast cancer. J Bodyw Mov Ther. 2008; 12(4):349–55. https://
doi.org/10.1016/j.jbmt.2008.04.043 PMID: 19083693
6. Fernandez-Lao C, Cantarero-Villanueva I, Fernandez-de-Las-Penas C, Del-Moral-Avila R, Arendt-Nielsen
L, Arroyo-Morales M. Myofascial trigger points in neck and shoulder muscles and widespread pressure
pain hypersensitivtiy in patients with postmastectomy pain: evidence of peripheral and central sensitiza-
tion. Clin J Pain. 2010; 26(9):798–806. https://doi.org/10.1097/AJP.0b013e3181f18c36 PMID: 20842013
7. Karki A, Simonen R, Malkia E, Selfe J. Impairments, activity limitations and participation restrictions 6
and 12 months after breast cancer operation. Rehabil Med Suppl. 2005; 37(3):180–8.
8. Simons DG, Travell JG, Simons LS. Myofascial pain and dysfunction: the trigger point manual, vol. 1.
Philadelphia: Lippincott William & Wilkins; 1999.
9. Mayoral Del Moral O, Torres Lacomba M, Russell IJ, Sanchez Mendez O, Sanchez Sanchez B. Validity
and Reliability of Clinical Examination in the Diagnosis of Myofascial Pain Syndrome and Myofascial
Trigger Points in Upper Quarter Muscles. Pain medicine. 2017.
10. De Groef A, Van Kampen M, Vervloesem N, De Geyter S, Dieltjens E, Christiaens MR, et al. An evalua-
tion tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Develop-
ment and interrater reliability. PloS one. 2017; 12(6):e0179116. https://doi.org/10.1371/journal.pone.
0179116 PMID: 28598978
11. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for
assessing the methodological quality of studies on measurement properties of health status measure-
ment instruments: an international Delphi study. Qual Life Res. 2010; 19(4):539–49. https://doi.org/10.
1007/s11136-010-9606-8 PMID: 20169472
12. Brusselaers N, Pirayesh A, Hoeksema H, Verbelen J, Blot S, Monstrey S. Burn scar assessment: A sys-
tematic review of objective scar assessment tools. Burns. 2010; 36(8):1157–64. https://doi.org/10.
1016/j.burns.2010.03.016 PMID: 20488623
13. Nedelec B, Correa JA, Rachelska G, Armour A, LaSalle L. Quantitative measurement of hypertrophic
scar: intrarater reliability, sensitivity, and specificity. J Burn Care Res. 2008; 29(3):489–500. https://doi.
org/10.1097/BCR.0b013e3181710869 PMID: 18388577
14. Nedelec B, Correa JA, Rachelska G, Armour A, LaSalle L. Quantitative measurement of hypertrophic
scar: interrater reliability and concurrent validity. J Burn Care Res. 2008; 29(3):501–11. https://doi.org/
10.1097/BCR.0b013e3181710881 PMID: 18388576
15. Draaijers LJ, Botman YA, Tempelman FR, Kreis RW, Middelkoop E, van Zuijlen PP. Skin elasticity
meter or subjective evaluation in scars: a reliability assessment. Burns 2004; 30(2):109–14. https://doi.
org/10.1016/j.burns.2003.09.003 PMID: 15019116
16. Held M, Rahmanian-Schwarz A, Rothenberger J, Schiefer J, Janghorban Esfahani B, Schaller HE,
et al. Alteration of biomechanical properties of burned skin. Burns. 2015; 41(4):789–95. https://doi.org/
10.1016/j.burns.2014.09.021 PMID: 25451148
17. Ohshima H, Kinoshita S, Oyobikawa M, Futagawa M, Takiwaki H, Ishiko A, et al. Use of Cutometer
area parameters in evaluating age-related changes in the skin elasticity of the cheek. Skin Res Tech-
nol). 2013; 19(1):e238–42.
18. Evans JD. Straightforward statistics for the behavioral sciences. Pacific Grove: Brooks/Cole Pub. Co.;
1996.
19. van Zuijlen PP, Angeles AP, Kreis RW, Bos KE, Middelkoop E. Scar assessment tools: implications for
current research. Plast Reconstr Surg. 2002; 109(3):1108–22. PMID: 11884845
20. Nguyen NT, Roberge D, Freeman CR, Wong C, Hines J, Turcotte RE. Skin Elasticity as a Measure of
Radiation Fibrosis: Is it Reproducible and Does it Correlate with Patient and Physician-reported Mea-
sures? Technol Cancer Res Treatt. 2014 Oct; 13(5):469–76.
21. Anthonissen M, Daly D, Fieuws S, Massage P, Van Brussel M, Vranckx J, et al. Measurement of elastic-
ity and transepidermal water loss rate of burn scars with the Dermalab((R)). Burns. 2013; 39(3):420–8.
https://doi.org/10.1016/j.burns.2012.07.026 PMID: 23000371
22. Boyce ST, Supp AP, Wickett RR, Hoath SB, Warden GD. Assessment with the dermal torque meter of
skin pliability after treatment of burns with cultured skin substitutes. J Burn Care Rehabil. 2000; 21(1 Pt
1):55–63.
23. Brandenburg JE, Eby SF, Song P, Zhao H, Brault JS, Chen S, et al. Ultrasound elastography: the new
frontier in direct measurement of muscle stiffness. Arch Phys Med Rehabil. 2014; 95(11):2207–19.
https://doi.org/10.1016/j.apmr.2014.07.007 PMID: 25064780
MAP-BC evaluation tool: Validity
PLOS ONE | https://doi.org/10.1371/journal.pone.0193915 March 9, 2018 12 / 12
